What is neoadjuvant therapy and why would chemo come before surgery

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Neoadjuvant Therapy

Neoadjuvant therapy is treatment given before the main surgery to remove a tumor. It's like a strategic warm-up before the main event. Let me explain why oncologists use this approach.

How It Works

Instead of going straight to surgery, your care team gives chemotherapy (or other treatments) first. The goals are:

  • Shrink the tumor so surgery is less extensive
  • Kill cancer cells that may have spread beyond what imaging can see
  • Test how your cancer responds to specific drugs
  • Preserve function by reducing the need for aggressive surgery

Why Chemo Before Surgery? The Clinical Reasoning

Oncologists think about cancer in three dimensions:

  1. The visible tumor - what shows up on scans
  2. Microscopic disease - cancer cells too small to see that may have spread
  3. Treatment response - how well your specific cancer responds to drugs

By giving chemotherapy first, doctors can:

  • Watch how your tumor shrinks (this tells them if the drugs are working)
  • Treat potential microscopic spread early
  • Sometimes avoid removing as much tissue, which preserves quality of life

When Is This Used?

According to NCCN Guidelines, neoadjuvant therapy is commonly recommended for:

  • Breast cancer (especially larger tumors or aggressive types)
  • Colorectal cancer (rectal cancers in particular)
  • Bladder cancer (muscle-invasive disease)
  • Esophageal cancer
  • Lung cancer (certain stages)

What Happens Next?

After chemotherapy completes (usually 3-6 months), your surgical team reassesses with imaging and then performs surgery to remove any remaining tumor.

Questions to Ask Your Oncologist

If neoadjuvant therapy is being discussed for your case:

  1. Why is neoadjuvant therapy recommended for my specific cancer?
  2. What chemotherapy drugs would be used, and what are the side effects I should expect?
  3. How will we measure if the treatment is working?
  4. What happens if the tumor doesn't shrink as expected?
  5. How will neoadjuvant therapy affect my surgery options?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2

It is h3k27 altered dmg h3k27m negative, egfr a289v myc tp53 mgmt methylated

Your tumor has specific genetic changes H3K27, EGFR, MYC, TP53, MGMT that your doctors will use to guide treatment decisions—these findings help deter